Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

14.3%

2 terminated out of 14 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

64%

9 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results71% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (1)
P 3 (1)
P 4 (8)

Trial Status

Completed5
Enrolling By Invitation3
Not Yet Recruiting2
Terminated2
Unknown2

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
Showing all 14 trials

Research Network

Activity Timeline